GLP-1 (active)
DRG International Inc.High Quality Assays with Reproducible and Reliable Results
High Quality Assays with Reproducible and Reliable Results
Acquiring high quality data doesn't need to be a challenge.
As concerns about PFAS health risks rise, advancements in chromatography are transforming our understanding of these persistent chemicals. Explore how innovative techniques enhance detection and analysis, paving the way for safer environments and better public health.
Roche and Atea partner to jointly develop AT-527, an orally administered direct-acting antiviral (DAA) currently in Phase 2 clinical trials
High Quality Assays with Reproducible and Reliable Results
The award money will help to expand Nanotrap Particle manufacturing capacity for COVID-19 testing
Starts Monday, July 6. Register for free today to stay informed on the latest techniques and technologies for COVID-19 and infectious disease research
New research assesses the interaction between the SARS-CoV-2 Spike S1 protein receptor binding domain (SARS-CoV-2 S1 RBD) and heparin
Recent funding from the BARDA award helped the company accelerate development and validation
The bioanalytical laboratory is the first of its type in the North East England
Motorized stage and custom-designed stitching software implemented across the range deliver large 4D images to advance long term live cell imaging studies
The THUNDER imager family enables users to decode 3D biology in real-time*
Discover how the use of high-throughput pipetting tools can facilitate this cutting-edge gene-editing tool
NESDEP detects pathogens in less than 90 minutes, and aims to provide significant cost savings whilst reducing the incidence of foodborne illnesses
Novel DNA repair enzyme gives insight into chemotherapy resistant tumors and neurodegenerative disorders